Daxor Corporation Common Stock DXR
$11.15
-1.03%
at last close
Market Cap$65.10 million
P/E Ratio—
Div Yield0.27%
Volume15.8K
52-Week Range
$8.56$14.76
Key Stats
- Today's Range
- $10.99 – $11.53
- 50-Day Range
- $9.55 – $12.07
- 52-Week Range
- $8.56 – $14.76
- Volume
- 16K shs
- Average Volume
- 20K shs
- Market Cap
- $65.10 million
- P/E Ratio
- —
- Dividend Yield
- 0.27%
Valuation
- P/E Ratio
- —
- Price / Book
- 1.80
- Price / Sales
- 45.01
Dividend
- Dividend Yield
- 0.27%
- Annual Dividend
- $0.03
- Payout Ratio
- —
- Ex-Dividend Date
- 2018-01-05
Short Interest
- Short Interest
- 0.00%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $1.45 million
- Net Income
- $-7,185,639
- Net Margin
- -496.81%
- Return on Equity
- -19.84%
- Debt-to-Equity
- —
About Daxor Corporation Common Stock
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. The company operates as a single business segment centered on the development, commercialization, and support of its proprietary blood volume analysis technology used by healthcare providers.
Related Stocks
Compare head-to-head: DXR vs SYK·DXR vs BSX·DXR vs RMD·DXR vs BAX
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.